![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
48-Week Safety and Efficacy On-Treatment Analysis of
Ibalizumab in Patients with Multi-Drug Resistant HIV-1
 
|
|
|
Brinda Emu, MD
Yale University
Presentation
Friday, October 6
IDWeek 2017  
Reported by Jules Levin  
Reported by Jules Levin
IDWeek2017/IDSA, October 4-8, 2017, San Diego
![1011171](../images/101117/101117-12/1011171.gif)
![1011172](../images/101117/101117-12/1011172.gif)
![1011173](../images/101117/101117-12/1011173.gif)
![1011174](../images/101117/101117-12/1011174.gif)
![1011175](../images/101117/101117-12/1011175.gif)
![1011176](../images/101117/101117-12/1011176.gif)
![1011177](../images/101117/101117-12/1011177.gif)
![1011178](../images/101117/101117-12/1011178.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|